
HH Biotechnology Holdings Company
Share · US40423K1007 (OTC)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of HH Biotechnology Holdings Company
No Price
Closing Price OTC 28.04.2026:
0,0001 USD
28.04.2026 20:00
Current Prices from HH Biotechnology Holdings Company
| Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
|---|---|---|---|---|---|
UTC |
HHBT
|
USD
|
28.04.2026 20:00
|
0,0001 USD
| 0,00 USD |
Company Profile for HH Biotechnology Holdings Company Share
HH Biotechnology Holdings Company engages in health and green industries. It focuses on planting and supplying macadamia nuts for use in foods, cooking oils, healthy products, toiletries, and cosmetics. The company was formerly known as Great China International Holdings, Inc. and changed its name to HH Biotechnology Holdings Company in August 2016. HH Biotechnology Holdings Company was incorporated in 1987 and is headquartered in Shenyang, the People's Republic of China.
Company Data
Name HH Biotechnology Holdings Company
Company HH Biotechnology Holdings Company
Primary Exchange
UTC
ISIN US40423K1007
Asset Class Share
Sector Real Estate
Industry Real Estate - Services
CEO Sheng Jiang
Country China
Currency USD
Employees 0,1 T
Address President Building, 110003 Shenyang
IPO Date 2005-03-28
Dividends from 'HH Biotechnology Holdings Company'
| Ex-Date | Dividend per Share |
|---|---|
| 29.06.2005 | 0,36 USD |
ID Changes
| Date | From | To |
|---|---|---|
| 15.11.2016 | GCIH | HHBT |
Ticker Symbols
| Name | Symbol |
|---|---|
| Over The Counter | HHBT |
More Shares
Investors who hold HH Biotechnology Holdings Company also have the following shares in their portfolio:
